48,830
edits
Difference between revisions of "TFEB-rearranged renal cell carcinoma"
Jump to navigation
Jump to search
TFEB-rearranged renal cell carcinoma (view source)
Revision as of 17:05, 9 October 2021
, 17:05, 9 October 2021→Molecular
(→IHC: cathepsin) |
|||
| Line 90: | Line 90: | ||
==Molecular== | ==Molecular== | ||
*t(6;11)(p21;q12) MALAT1<ref>{{OMIM|607924}}</ref>/TFEB.<ref name=Ref_WMSP281>{{Ref WMSP|281}}</ref> | *t(6;11)(p21;q12) MALAT1<ref>{{OMIM|607924}}</ref>/TFEB.<ref name=Ref_WMSP281>{{Ref WMSP|281}}</ref> | ||
Others - less common:<ref name=pmid33208882>{{cite journal |vauthors=Caliò A, Harada S, Brunelli M, Pedron S, Segala D, Portillo SC, Magi-Galluzzi C, Netto GJ, Mackinnon AC, Martignoni G |title=TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 |journal=Mod Pathol |volume=34 |issue=4 |pages=842–850 |date=April 2021 |pmid=33208882 |doi=10.1038/s41379-020-00713-6 |url=}}</ref> | |||
*ACTB-TFEB. | |||
*NEAT1-TFEB. | |||
==See also== | ==See also== | ||